- Home
- RVMD vs SOLS Comparison
RVMD vs SOLS Comparison
Compare RVMD & SOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | SOLS |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 12.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RVMD | SOLS |
|---|---|---|
| Price | $103.19 | $76.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 4 |
| Target Price | ★ $114.63 | $72.75 |
| AVG Volume (30 Days) | 1.7M | ★ 3.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.02 |
| Revenue Next Year | $552.08 | $4.78 |
| P/E Ratio | ★ N/A | $54.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.17 | $40.43 |
| 52 Week High | $124.49 | $84.44 |
Technical Indicators
Market Signals| Indicator | RVMD | SOLS |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 61.49 |
| Support Level | $92.76 | $47.09 |
| Resistance Level | $124.49 | $84.44 |
| Average True Range (ATR) | 3.62 | 4.10 |
| MACD | 0.23 | -0.33 |
| Stochastic Oscillator | 67.28 | 60.56 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About SOLS Solstice Advanced Materials Inc.
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.